503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
9.48%
Net income growth 1.25-1.5x ORCL's 6.73%. Bruce Berkowitz would verify whether cost discipline or revenue gains drive the outperformance.
27.12%
D&A growth well above ORCL's 12.20%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
308.71%
Deferred tax of 308.71% while ORCL is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
No Data
No Data available this quarter, please select a different quarter.
167.27%
Well above ORCL's 114.83% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
167.27%
Growth well above ORCL's 114.83%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-28.44%
Both negative yoy, with ORCL at -108.13%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
50.67%
Operating cash flow growth below 50% of ORCL's 190.04%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
34.06%
CapEx growth well above ORCL's 59.38%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-33.33%
Negative yoy acquisition while ORCL stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-29.37%
Negative yoy purchasing while ORCL stands at 53.15%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
19.36%
We have some liquidation growth while ORCL is negative at -0.93%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
No Data
No Data available this quarter, please select a different quarter.
-108.37%
We reduce yoy invests while ORCL stands at 613.67%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
10.36%
Buyback growth below 50% of ORCL's 47.92%. Michael Burry suspects fewer capital returns to shareholders vs. competitor, unless expansions hold higher ROI.